Nexalin Technology's Chief Medical Officer Invests $7,700 in Company Stock Amidst Market Volatility
2025-01-24MSN
In a notable move, the Chief Medical Officer of Nexalin Technology, Inc. (NASDAQ:NXL) has purchased $7,700 worth of common stock. This investment comes at a time when the stock has experienced significant fluctuations, with a 18% drop in the past wee ...Read more
Recommendations
Loading...